I appreciate your response, but still not a full answer to my question. One PR firm I spoke to suggested contacting the Montefiore Doctor in the Bronx and the patients who were successfully treated with Leronlimab and interviewing them. And then trying to get the story publicized. Maybe I'll do that.Perhaps our fellow investors in areas, such as Los Angeles where the drug has demonstrated success could reach out to Dr. Yang and follow a similar approach. This should be done in consultation with CytoDyn so the company is in the loop as far as content. Curious to see the Board's response.